Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

Stem-cell therapy shows promise for skin conditions but needs more research.

Dermatoscopy helps diagnose hair and scalp disorders in people with Afro-textured hair, but more research is needed for better understanding and treatment.

Hair and nails can help diagnose diseases, with nail issues often linked to skin conditions and hair loss having various causes and treatments.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

New biopsy techniques and tools improve alopecia diagnosis, and both too much and too little selenium can cause hair loss.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Dermoscopy helped diagnose discoid lupus erythematosus in two patients without needing skin biopsies.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Late onset SLE has different symptoms and antibody profiles compared to young onset SLE.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Woman has discoid lupus, frontal fibrosing, and androgenetic alopecia.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

SLE is rare in Uganda but often has complications and overlaps with rheumatoid arthritis.

Diagnosing new systemic lupus during pregnancy is hard but important for the health of the mother and baby.

Skin issues like hair loss, rash, and sensitivity to sunlight are key signs of lupus activity.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

SLE and DM can coexist but are rare and need careful evaluation.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.